Skip to main content

Table 4 Common immune-related adverse events

From: Preliminary evidence for endoscopic surgery combined with postoperative anti-PD-1 immunotherapy in advanced recurrent nasopharyngeal carcinoma

Complications

Toripalimab (n = 4)

Camrelizumab (n = 6)

Rash

1

1

Asthenia

0

1

Nausea

1

1

Pruritus

0

1

Hypothyroidism

1

0

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us